Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47%TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:PROF; TSX:PRN) ...

A Finnish cohort study of 644 older men with hip fracture found that pre-fracture fecal incontinence independently predicted one-year mortality, while urinary incontinence was strongly linked to ...

September 30, 2026, 10:01 to October 7, 2026, 10:01 (JST)This week, progress was made in preparing for U.S. regulatory ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...

When prostate cancer returns or is at high risk of returning after surgery, radiation to the prostate bed (the area where the prostate used to be) is often recommended. The standa ...

Medicana Health Group is highlighting the role of robot-assisted surgery in prostate cancer treatment as a 2026 research ...

For robotic radical prostatectomy, the Retzius-sparing approach permits early urinary continence recovery but prostate cancer outcomes might be compromised.

Roughly 1 in 8 men receive a prostate cancer diagnosis at some stage in their lives, but only about 1 in 44 men will die of ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...